{"nct_id":"NCT06465433","title":"Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2022-11-08","start_date_type":"ACTUAL","primary_completion_date":"2027-08-29","primary_completion_date_type":"ESTIMATED","completion_date":"2027-08-29","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["INCY"]}